Chiara Biosciences Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Chiara Biosciences General Information

Description

Developer of small-molecule therapeutics designed for targeted protein degradation. The company uses a modular linker system to enable intracellular self-assembly of bifunctional degraders that engage E3 ligases and target proteins, offering oral bioavailability, central nervous system penetration, resistance to the hook effect, and compatibility with high-throughput combinatorial screening, enabling pharmaceutical researchers scalable and reusable drug discovery across internal and collaborative pipelines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6635 South Dayton Street
  • Suite Number 310
  • Greenwood Village, CO 80111
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 6635 South Dayton Street
  • Suite Number 310
  • Greenwood Village, CO 80111
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chiara Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 06-Feb-2026 Completed Generating Revenue
3. Early Stage VC 07-Mar-2025 Completed Generating Revenue
2. Accelerator/Incubator Completed Stealth
1. University Spin-Out 01-Jan-2024 Completed Stealth
To view Chiara Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Chiara Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chiara Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Impact Assets Impact Investing Minority
Rose Ventures Venture Capital Minority
This is Water Venture Capital Minority
Cornell University University
AIM-HI Accelerator/Incubator
To view Chiara Biosciences’s complete investors history, request access »

Chiara Biosciences FAQs

  • When was Chiara Biosciences founded?

    Chiara Biosciences was founded in 2024.

  • Where is Chiara Biosciences headquartered?

    Chiara Biosciences is headquartered in Greenwood Village, CO.

  • What is the size of Chiara Biosciences?

    Chiara Biosciences has 7 total employees.

  • What industry is Chiara Biosciences in?

    Chiara Biosciences’s primary industry is Drug Discovery.

  • Is Chiara Biosciences a private or public company?

    Chiara Biosciences is a Private company.

  • What is Chiara Biosciences’s current revenue?

    The current revenue for Chiara Biosciences is .

  • Who are Chiara Biosciences’s investors?

    Impact Assets, Rose Ventures, This is Water, Cornell University, and AIM-HI have invested in Chiara Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process